There were many predictive models for assessing CLNM possibility in cN0 PTMC, but their models only incorporated clinical baseline data such as tumor characteristics, ultrasound and CT examination features or just included BRAF mutation result (50–52). The gene discussed is BRAF; the disease is neoplasm.